High-flow oxygen didn't help patients survive acute hypoxemic respiratory failure better than standard oxygen, the SOHO trial showed. Mortality at day 28 came out an identical 14.6% in patients ...
Data are needed on the effect of oxygen delivered through a high-flow nasal cannula, as compared with standard oxygen therapy, on intubation and mortality in patients with acute hypoxemic respiratory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results